Showing results (151-160 of 792) with videos related to
Sort By:
Pageof 80
Molecular Cancer Therapeutics|July 3, 2007
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathwayHeath A Elrod, Yi-Dan Lin, Ping Yue, et al.Cancer Letters|July 31, 2018
Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacyGuoqing Qian, Weilong Yao, Shuo Zhang, et al.The Journal of Biological Chemistry|December 25, 2007
Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529Sumin Kang, Shaozhong Dong, Ailan Guo, et al.British Journal of Haematology|May 10, 2017
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myelomaShaji Kumar, Philippe Moreau, Parameswaran Hari, et al.Journal of Ayurveda and Integrative Medicine|September 26, 2023
Practice, prescription habits, experience and perception of Indian homeopathic practitioners in treatment of diabetes mellitus: An online observational studyRoja Varanasi, Amit Srivastava, Shaji Kumar Rt, et al.Leukemia|January 27, 2019
The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologiesTaylor Harding, Linda Baughn, Shaji Kumar, et al.Clinical Lymphoma, Myeloma & Leukemia|December 23, 2023
Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical PracticeRitu Gupta, Dragan Jevremovic, Smith J Mathew, et al.Cancer|April 7, 2006
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myelomaBrett T Brinker, Edmund K Waller, Traci Leong, et al.European Journal of Cancer (Oxford, England : 1990)|September 9, 2025
AI-informed retinal biomarkers predict 10-year risk of onset of multiple hematological malignanciesAmritpal Singh, Ajay K Nooka, Gourav Modanwal, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
High-Risk Multiple Myeloma: Redefining Risk and Rethinking TherapyGareth J Morgan, Dennis D Lee, Nisha S Joseph, et al.Pageof 80